CSI Market
Sign In | Register

Artelo Biosciences Inc (ARTL) Annual Balance Sheets

Annual · GAAP · USD millions
Access ARTL quarterly Balance Sheets →
Balance sheet data covering Artelo Biosciences Inc–Aug 31 2021 offers a view into how Dec 31 2025's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Aug 31 2021)
Assets
Cash & cash equivalent0.00
Marketable Securities, Total MA0.00
Cash & Short-term Investments0.00
Other Current Assets0.60
Prepaid Expense And Other Assets Current0.10
Total Current Assets0.70
Intangible Assets2.04
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent0.07
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.60
Operating Lease Right Of Use Asset0.06
Total Assets2.80
Liabilities
Accounts Payable and Accrued Liabilities, Current LI3.04
Accrued Liabilities, Current AC0.01
Convertible Notes Payable, Current NO0.44
Other Liabilities, Current0.56
Total Current Liabilities4.04
Total Long-term Debt0.00
Other liabilities, Noncurrent0.03
OperatingLeaseLiabilityNoncurrent0.03
Due To Related Parties0.00
Operating Lease Liability Current0.17
Total Liabilities4.07
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock62.01
Retained Earnings / Accumulated Deficit-63.02
Other Equity-0.27
Common Stockholder's Equity-1.27
Total Stockholder's Equity-1.27
Liabilities & Stockholder's Equity2.80
4 historic quarters locked

Sign in to unlock the full Artelo Biosciences Inc balance sheet history.

Sign In Create Free Account

About Artelo Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: artl_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001640334-26-000368

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.